全球骨生物製药市场规模、份额、趋势和成长分析报告（2026-2034年）

预计整形外科生物製剂市场将从 2025 年的 81.1 亿美元成长到 2034 年的 139.6 亿美元，2026 年至 2034 年的复合年增长率为 6.21%。

随着再生医学在肌肉骨骼治疗中日益重要，整形外科生物製剂市场正经历快速成长。源自天然材料的整形外科生物製剂，例如骨移植、富血小板血浆和干细胞疗法，正被越来越多地用于促进癒合、增强组织再生并缩短整形外科手术后的恢復时间。运动伤害、骨关节炎和创伤相关疾病发生率的上升，推动了对这些先进治疗方法的需求。

未来的成长将得益于生物材料、3D列印和生物工程支架领域的突破性进展，这些进展将改善组织整合和长期功能。研究方向着重于开发具有更高生物活性和可控释放机制的新一代整形外科生物製剂，以确保更有效的治疗效果。整形外科生物製剂与微创手术技术的结合有望提高手术效率，减少併发症，并促进其在全球整形外科中心的广泛应用。

对临床试验投入的增加以及对创新治疗方法的监管支持力度加大，进一步巩固了市场前景。个人化医疗方法，例如患者特异性移植和个人化细胞疗法，正在塑造未来。随着医疗保健支出的增长和人们对再生医学解决方案认识的提高，整形外科生物製剂市场有望发展成为先进整形外科医学的基础。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球骨生物製药市场：依产品划分

• 市场分析、洞察与预测
• 去钙骨基质（DBM）
• 羟基磷灰石（HAp）
• 透明质酸（HA）
• 硫酸钙基质
• AZA2-磷酸三钙（AZA2-TCP）
• AZA2-TCP+HAp
• DBM+HA
• AZA2-TCP+PLGA
• 再生医学
• 生长因子

第五章 全球骨生物製药市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 整形外科诊所
• 其他（耳鼻喉科诊所等）

第六章 全球骨生物製药市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Arthrex Inc
  • ATEC Spine Inc
  • Bioventus
  • Exactech Inc
  • Globus Medical
  • Integra Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • MTF Biologics
  • NORAKER
  • RTI Surgical
  • Stryker
  • Zimmer Biomet

The Orthobiologics Market size is expected to reach USD 13.96 Billion in 2034 from USD 8.11 Billion (2025) growing at a CAGR of 6.21% during 2026-2034.

The orthobiologics market is experiencing rapid development as regenerative medicine becomes central to musculoskeletal treatments. Derived from natural substances such as bone grafts, platelet-rich plasma, and stem cell therapies, orthobiologics are being increasingly utilized to accelerate healing, enhance tissue regeneration, and reduce recovery times in orthopedic procedures. Rising incidences of sports injuries, osteoarthritis, and trauma-related conditions are fueling demand for these advanced therapies.

Future growth will be driven by breakthroughs in biomaterials, 3D printing, and bioengineered scaffolds that improve integration and long-term functionality. Research pipelines are focusing on next-generation orthobiologics with higher bioactivity and controlled release mechanisms, ensuring more effective outcomes. The integration of orthobiologics with minimally invasive surgical techniques is expected to enhance procedural efficiency, reduce complications, and expand adoption across orthopedic centers globally.

The market outlook is strengthened by increasing investments in clinical trials and regulatory support for innovative therapies. Personalized medicine approaches, such as patient-specific grafts and tailored cellular therapies, are shaping the future landscape. With rising healthcare expenditures and growing awareness of regenerative solutions, the orthobiologics market is positioned to evolve as a cornerstone of advanced orthopedic care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Demineralized Bone Matrix (DBM)
• Hydroxyapatite (HAp)
• Hyaluronic acid (HA)
• Calcium Sulfate Matrix
• AZA2-tricalcium phosphate (AZA2-TCP)
• AZA2-TCP + HAp
• DBM + HA
• AZA2-TCP + PLGA
• Regenerative medicine
• Growth Factors

By End-user

• Hospitals
• Orthopedic Clinics
• Others (ENT Clinics, etc.)

COMPANIES PROFILED

• Arthrex Inc, ATEC Spine Inc, Bioventus, Exactech Inc, Globus Medical, Integra Lifesciences Corporation, Johnson Johnson, Medtronic plc, MTF Biologics, NORAKER, RTI Surgical, Stryker, Zimmer Biomet
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORTHOBIOLOGICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Demineralized Bone Matrix (DBM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hydroxyapatite (HAp) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hyaluronic acid (HA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Calcium Sulfate Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. AZA2-tricalcium phosphate (AZA2-TCP) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. AZA2-TCP + HAp Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. DBM + HA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. AZA2-TCP + PLGA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Regenerative medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Growth Factors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORTHOBIOLOGICS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others (ENT Clinics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORTHOBIOLOGICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ORTHOBIOLOGICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Arthrex Inc
  • 8.2.2 ATEC Spine Inc
  • 8.2.3 Bioventus
  • 8.2.4 Exactech Inc
  • 8.2.5 Globus Medical
  • 8.2.6 Integra Lifesciences Corporation
  • 8.2.7 Johnson & Johnson
  • 8.2.8 Medtronic Plc
  • 8.2.9 MTF Biologics
  • 8.2.10 NORAKER
  • 8.2.11 RTI Surgical
  • 8.2.12 Stryker
  • 8.2.13 Zimmer Biomet